Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
10/10/2002 | CA2442533A1 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
10/10/2002 | CA2442531A1 Peptides and antibodies to muc 1 proteins |
10/10/2002 | CA2442363A1 Reducing the immunogenicity of fusion proteins |
10/10/2002 | CA2442134A1 Compositions and methods for diagnosing or treating psoriasis |
10/10/2002 | CA2442074A1 Methods of detecting early renal disease in animals |
10/10/2002 | CA2442064A1 G-protein coupled receptors |
10/10/2002 | CA2442062A1 Secreted proteins |
10/10/2002 | CA2441863A1 Drugs containing genetically modified antibody against ganglioside gd3 |
10/10/2002 | CA2441654A1 Cytoskeleton-associated proteins |
10/10/2002 | CA2441382A1 A hepatitis b virus surface antigen mutant and methods of detection thereof |
10/10/2002 | CA2440831A1 Combination therapy using cd40 and cd20 ligands |
10/10/2002 | CA2438030A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
10/10/2002 | CA2437099A1 Methods and compositions for treatment of immune dysfunction disorders |
10/10/2002 | CA2437095A1 Methods and compositions for modulating the immune system of animals |
10/10/2002 | CA2429265A1 Mammalian alpha-helical protein-53 |
10/10/2002 | CA2426710A1 Antibodies that immunospecifically bind to trail receptors |
10/09/2002 | EP1247865A2 Antibody for use in therapy |
10/09/2002 | EP1247818A2 Prion and viral clearance process of immunoglobulin preparations |
10/09/2002 | EP1247817A2 Human CD23-like protein and nucleic acids encoding it |
10/09/2002 | EP1247816A1 Immunogen, antivenom and vaccine against the venom of the black widow spider |
10/09/2002 | EP1247100A1 Interaction between cd14 and hbv components |
10/09/2002 | EP1247099A2 Methods and compositions for detecting hepatitis e virus |
10/09/2002 | EP1247094A2 ASSAYS FOR DETECTION OF i BACILLUS ANTHRACIS /i |
10/09/2002 | EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
10/09/2002 | EP1246923A2 Dna modification proteins |
10/09/2002 | EP1246918A2 Secreted proteins |
10/09/2002 | EP1246917A2 Human stra6 polypeptides |
10/09/2002 | EP1246905A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
10/09/2002 | EP1246848A1 GENETIC VACCINES FOR THE PRODUCTION OF CHICKEN EGG-YOLK ANTIBODIES AGAINST ENTEROTOXIGENIC i ESCHERICHIA COLI /i AND OTHER PATHOGENS |
10/09/2002 | EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
10/09/2002 | EP1246846A2 Soluble interleukin-20 receptor |
10/09/2002 | EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof |
10/09/2002 | EP1246843A1 Novel fgf homolog zfgf12 |
10/09/2002 | EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
10/09/2002 | EP1246841A1 Transcription factors containing two potential dna binding motifs |
10/09/2002 | EP1246840A2 Human and parasite orphan receptor proteins |
10/09/2002 | EP1246643A2 Dna vaccines encoding antigen linked to a domain that binds cd40 |
10/09/2002 | EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
10/09/2002 | EP1200475A4 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
10/09/2002 | EP0979277A4 Novel human tumour suppressor gene |
10/09/2002 | EP0973550B1 Antagonistic anti-avb3 integrin antibodies |
10/09/2002 | EP0960336B1 Peptide reagent for the detection of human cytomegalovirus (cmv) |
10/09/2002 | EP0868434B1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
10/09/2002 | EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
10/09/2002 | EP0769025B1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
10/09/2002 | EP0726915B1 A ligand capable of binding to the adenosine deaminase binding-site of cd26 |
10/09/2002 | EP0640098B1 Canine coronavirus s gene and uses therefor |
10/09/2002 | CN1373805A Antigenic meningococcal peptides |
10/09/2002 | CN1373672A Blocking immune response to foreign antigen using antagonist which binds to CD20 |
10/09/2002 | CN1373671A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
10/09/2002 | CN1373220A Coding sequence of human tonB-dependent receptor protein and its preparing process and application |
10/08/2002 | US6462189 Fibronectins; monobody loop region varies with wild-type by deletions; binds to specific binding partner |
10/08/2002 | US6462177 Mammalian blood loss-induced gene, kd312 |
10/08/2002 | US6461850 Peptides selected by homology and/or structural relatedness to known protease proteins of the choriolytic hatching protease subfamily and expression pattern observed |
10/08/2002 | US6461848 Degrades heparin sulfate preventing deposits of beta-amyloid senile plaques |
10/08/2002 | US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
10/08/2002 | US6461824 Production of chimeric antibodies with specificity to human tumor antigens |
10/08/2002 | US6461823 Death domain containing receptor-4 antibodies |
10/08/2002 | US6461821 Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor |
10/08/2002 | US6461811 Gamma-herpes virus DNA and methods of use |
10/08/2002 | US6461612 Genetic engineering |
10/08/2002 | US6461609 Recombinant α-galactosidase a therapy for Fabry disease |
10/08/2002 | CA2254145C Improved process to stabilize proteins |
10/08/2002 | CA2231046C Human protein kinases hyak3 |
10/08/2002 | CA2047119C Vitro processing of fusion proteins |
10/03/2002 | WO2004031223A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
10/03/2002 | WO2002077648A2 Pathogenic and commensal vaccine antigens |
10/03/2002 | WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
10/03/2002 | WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same |
10/03/2002 | WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
10/03/2002 | WO2002077261A2 Human potassium channel |
10/03/2002 | WO2002077243A1 Diagnosis of cancer or benign tumour using the aberrant expression product of the klk4 gene |
10/03/2002 | WO2002077237A2 Transporters and ion channels |
10/03/2002 | WO2002077232A2 Compositions and methods relating to breast specific genes and proteins |
10/03/2002 | WO2002077226A1 Prostaglandin ep1 receptor |
10/03/2002 | WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
10/03/2002 | WO2002077213A2 New elongase gene and production of δ9-polyunsaturated fatty acids |
10/03/2002 | WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor |
10/03/2002 | WO2002077180A2 Novel nucleic acids and polypeptides |
10/03/2002 | WO2002077179A2 Leinamycin biosynthesis gene cluster and its components and their uses |
10/03/2002 | WO2002077174A2 Human cytokine receptor |
10/03/2002 | WO2002077172A2 Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors |
10/03/2002 | WO2002077034A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
10/03/2002 | WO2002077033A1 Antibodies against cancer |
10/03/2002 | WO2002077032A1 Antibodies that dissolve arterial thrombi |
10/03/2002 | WO2002077029A2 Cd19-specific redirected immune cells |
10/03/2002 | WO2002077028A1 Polypeptides and nucleic acids for bolekine |
10/03/2002 | WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same |
10/03/2002 | WO2002077023A2 A new essential downstream component of the wingless signalling pathway |
10/03/2002 | WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids |
10/03/2002 | WO2002076578A1 Control of glycoforms in igg |
10/03/2002 | WO2002076504A1 Remedies for inflammatory bowel diseases |
10/03/2002 | WO2002076503A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
10/03/2002 | WO2002076502A1 Human medical treatment by application of immunoglobulin a |
10/03/2002 | WO2002076501A2 Blood cell production via activation of the hemoglobin scavenger receptor |
10/03/2002 | WO2002076499A2 Combination treatment of pancreatic cancer |
10/03/2002 | WO2002076497A2 Method and composition |
10/03/2002 | WO2002076494A2 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS |
10/03/2002 | WO2002076486A2 Histidine-rich glycoprotein |
10/03/2002 | WO2002076406A2 Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them |